Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Leukemia 34Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Lymphoma 27Burkitt Lymphoma 27Lymphoma, Non-Hodgkin 22Lymphoma, Large B-Cell, Diffuse 22Myelodysplastic Syndromes 20Leukemia, Myeloid, Chronic-Phase 20Lymphoma, Follicular 19Leukemia, Lymphocytic, Chronic, B-Cell 18Leukemia, Myeloid, Accelerated Phase 17Multiple Myeloma 16Lymphoma, Large-Cell, Immunoblastic 15Blast Crisis 15Myeloproliferative Disorders 14Leukemia, Myeloid, Acute 14Dendritic Cell Sarcoma, Interdigitating 14Recurrence 13Lymphoma, Mantle-Cell 13Lymphoma, B-Cell, Marginal Zone 13Graft vs Host Disease 13Leukemia, Myelomonocytic, Chronic 12Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 12Hodgkin Disease 11Congenital Abnormalities 11Neoplasms, Plasma Cell 10Myelodysplastic-Myeloproliferative Diseases 10Anemia, Refractory, with Excess of Blasts 9Primary Myelofibrosis 8Lymphoma, Large-Cell, Anaplastic 8

Interventions

Sunitinib 5pembrolizumab 4Paclitaxel 4Carboplatin 4Radiotherapy 3Cyclophosphamide 3Cisplatin 3selinexor 2lenvatinib 2Taxes 2Ramucirumab 2Octreotide 2N,1,4,4-tetramethyl-8-((4-(4-methylpiperazin-1-yl)phenyl)amino)-4,5-dihydro-1H-pyrazolo(4,3-h)quinazoline-3-carboxamide 2Methylprednisolone 2Erlotinib Hydrochloride 2Chemoradiotherapy 2zimberelimab 1saracatinib 1regorafenib 1epacadostat 1envafolimab 1belinostat 1avelumab 1atezolizumab 1amrubicin 1alovudine 1TP protocol 1Radiofrequency Ablation 1Radiation Dose Hypofractionation 1Prednisone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Thymoma × Methylprednisolone × Clear all
NCT06730308 2024-12-12

Glucocorticoids Combined With Concurrent Chemoradiotherapy for Unresectable Thymoma

Sun Yat-sen University

Phase 2 Recruiting
45 enrolled
Thoracic

Thymoma

NCT00003662 2011-03-07

Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases

Roswell Park Cancer Institute

Phase 2 Completed
90 enrolled
Classical hematologyMyeloidOther hematologic neoplasmThoracic

Anemia, Refractory, Graft vs Host Disease, Leukemia, Myelodysplastic Syndromes, Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡